Why the Patient–Site Relationship Is the Most Critical Factor in Clinical Trials
Steve Rosenberg explains why clinical trials succeed or fail based on one critical factor: treating patients as partners—and designing technology around their experience, not the protocol.
|
|
In this episode of Life Sciences Decoded, Susan Najjar sits down with Steve Rosenberg, CEO of uMotif and a legendary leader in clinical trial technology, to explore one of the most overlooked truths in clinical research: patients are the real heroes of clinical trials.
Steve shares why the most important relationship in any trial isn’t between sponsor and CRO, but between the patient and the site—and how trust, empathy, and thoughtful technology design directly impact compliance, data quality, and trial success. From patient-reported outcomes and eConsent to why technology should feel “invisible,” this conversation examines how patient-centric platforms like uMotif are reshaping the clinical trial experience for both patients and sites—and why the industry must do better. |
|
What makes patients stay in clinical trials?
|
Why Patients Get Lost in Clinical Trials
|
The Problem Isn’t Clinical Trials, It’s Technology
|